BRK-A vs HUM
Berkshire Hathaway Inc. and Humana Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BRK-A | HUM |
|---|---|---|
| Revenue | $371.4B | $129.7B |
| Net income | $67.0B | $1.2B |
| Gross margin | — | — |
| Net margin | 18.1% | 0.9% |
| Return on equity | 9.8% | 7.0% |
| Diluted EPS | — | $9.84 |
| Dividend / share | — | $3.54 |
| Payout ratio | — | 36.2% |
| Free cash flow | $25.0B | $375.0M |
| Equity | $717.4B | $17.7B |
| Net debt / equity | — | 0.46× |
| Current ratio | — | 2.00× |
| Revenue CAGR 5y | 8.6% | 10.9% |
| Profit CAGR 5y | 9.5% | −18.8% |
BRK-A bills 2.9× the revenue of HUM, and keeps more of each dollar of revenue as profit (18.1% against 0.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | BRK-A | HUM |
|---|---|---|
| FY2025 | $371.4B | $129.7B |
| FY2024 | $371.4B | $117.8B |
| FY2023 | $364.5B | $106.4B |
| FY2022 | $302.0B | $92.9B |
| FY2021 | $276.2B | $83.1B |
| FY2020 | $245.6B | $77.2B |
| FY2019 | $254.6B | $64.9B |
| FY2018 | $247.8B | $56.9B |
| FY2017 | $239.9B | $53.8B |
| FY2016 | $215.1B | $54.4B |
Net income by year
Bottom line
| Fiscal year | BRK-A | HUM |
|---|---|---|
| FY2025 | $67.0B | $1.2B |
| FY2024 | $89.0B | $1.2B |
| FY2023 | $96.2B | $2.5B |
| FY2022 | $-22.8B | $2.8B |
| FY2021 | $89.9B | $2.9B |
| FY2020 | $42.5B | $3.4B |
| FY2019 | $81.4B | $2.7B |
| FY2018 | $4.0B | $1.7B |
| FY2017 | $44.9B | $2.4B |
| FY2016 | $24.1B | $614.0M |